相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Massively Parallel Sequencing Identifies Recurrent Mutations in TP53 in Thymic Carcinoma Associated with Poor Prognosis
Andre L. Moreira et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney
Hitomi Ueno-Yokohata et al.
NATURE GENETICS (2015)
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Lu Jiang et al.
NATURE GENETICS (2015)
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Can Kucuk et al.
NATURE COMMUNICATIONS (2015)
Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
Seungbok Lee et al.
ONCOTARGET (2015)
Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas
Toru Furukawa et al.
SCIENTIFIC REPORTS (2015)
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley et al.
BLOOD (2015)
Whole exome sequencing hints at a unique mutational profile of paediatric T-cell lymphoblastic lymphoma
Bettina R. Bonn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome
Austin G. Kulasekararaj et al.
BLOOD (2014)
Genetic alterations of the cohesin complex genes in myeloid malignancies
Swapna Thota et al.
BLOOD (2014)
Clarifying the Impact of Polycomb Complex Component Disruption in Human Cancers
Yukiya Yamamoto et al.
MOLECULAR CANCER RESEARCH (2014)
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
A. Bouchekioua et al.
LEUKEMIA (2014)
Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan
Hiroshi Kimura et al.
LEUKEMIA & LYMPHOMA (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
Mamiko Sakata-Yanagimoto et al.
NATURE GENETICS (2014)
Genetic landscape of esophageal squamous cell carcinoma
Yi-Bo Gao et al.
NATURE GENETICS (2014)
Activated Janus Kinase 3 expression not by activating mutations identified in Natural Killer/T-cell lymphoma
Ying Guo et al.
PATHOLOGY INTERNATIONAL (2014)
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
Jack F. Shern et al.
CANCER DISCOVERY (2014)
Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations
Franck Tirode et al.
CANCER DISCOVERY (2014)
Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems
Carol Ying-Ying Szeto et al.
FEBS OPEN BIO (2014)
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders
Frederik Damm et al.
BLOOD (2013)
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs
Alexis Christoforides et al.
BMC GENOMICS (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia
Enrico Tiacci et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion
Gaelle Pierron et al.
NATURE GENETICS (2012)
Janus Kinase 3-Activating Mutations Identified in Natural Killer/T-cell Lymphoma
Ghee Chong Koo et al.
CANCER DISCOVERY (2012)
Natural killer-cell differentiation by myeloid progenitors
Bartosz Grzywacz et al.
BLOOD (2011)
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype
Vera Grossmann et al.
BLOOD (2011)
Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
Kennosuke Karube et al.
BLOOD (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
Motoko Yamaguchi et al.
CANCER SCIENCE (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Implications of NRAS mutations in AML:: a study of 2502 patients
Ulrike Bacher et al.
BLOOD (2006)
Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR
D Ng et al.
NATURE GENETICS (2004)
Production of high-titer Epstein-Barr virus recombinants derived from akata cells by using a bacterial artificial chromosome system
T Kanda et al.
JOURNAL OF VIROLOGY (2004)
Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
S Imashuku et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities
M Fujita et al.
PATHOLOGY INTERNATIONAL (2000)
分享论文
